ImmunogenX
Pharmaceutical ManufacturingView the employees at
ImmunogenX-
Vasiliy Loskutov Project Analyst at ImmunogenX
-
Top 10%
Vasiliy Loskutov Project Analyst at ImmunogenX-
Irvine
-
Top 10%
Matt Dickason Chief Operating Officer at ImmunogenX-
Newport Beach
-
Rising Star
Overview
ImmunogenX, Inc. is a clinical-stage company founded in 2013 and supported by a team of world renowned scientists and collaborators. ImmunogenX was formed to address critical needs for individuals with suspected or diagnosed celiac disease. ImmunogenX is currently conducting two Phase 2b clinical research trials and has completed one study on latiglutenase, an investigational medication designed to relieve common symptoms suffered by those with celiac disease.
-